Restrictive cardiomyopathy
Barbara Bellmann(Franklin University), Andreas J. Morguet(Charité - Universitätsmedizin Berlin), Brunilda Alushi(Deutsches Herzzentrum der Charité), Ulf Landmesser(Deutsches Herzzentrum der Charité), Boris Bigalke(Charité - Universitätsmedizin Berlin)
Cited by 3
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k